when were glp 1 agonists discovered PDB-101: Molecule of the Month: GLP-1 Receptor Navigating the -tides: Medication-Assisted Weight
Description
Laboratory studies have demonstrated that GLP-1 receptor activation can reduce the production of pro-inflammatory cytokines, including tumour necrosis factor-alpha (TNF-), interleukin-6 (IL-6), and interleukin-1 beta (IL-1)
If GLP-1 drugs can help, even just a little, then we need to pay attention
Retatrutide, with its more aggressive weight loss, may produce more noticeable hair thinning than milder alternatives
The leading entities
Some prescribers combine phentermine with GLP-1 agonists for enhanced effect
